Methacetin Breath Test (MBT) ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 212 | Tricuspid atresia | 1 |
212. Tricuspid atresia
Clinical trials : 6 / Drugs : 8 - (DrugBank : 7) / Drug target genes : 8 - Drug target pathways : 12
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04176458 (ClinicalTrials.gov) | April 21, 2019 | 12/2/2019 | Methacetin Breath Test in Patients With Liver Disease Secondary to Heart Disease | Non-invasive Assessment of Liver Function in Patients Undergoing Heart and Liver Transplant Evaluation | Dilated Cardiomyopathy;Tricuspid Atresia | Device: Methacetin Breath Test (MBT) | Northwestern University | NULL | Recruiting | 18 Years | N/A | All | 20 | N/A | United States |